Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

NCT06665997 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT06665997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06665997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
Lead sponsor
University of Pennsylvania
Phase
Phase 4
Overall status
Recruiting
Start date
June 26, 2025
Completion date
July 31, 2028
Enrollment
65 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease (scd), vaso-occlusive pain episode in sickle cell disease